Oric Pharmaceuticals Reports on Shareholder Vote
Ticker: ORIC · Form: 8-K · Filed: Jun 14, 2024 · CIK: 1796280
| Field | Detail |
|---|---|
| Company | Oric Pharmaceuticals, Inc. (ORIC) |
| Form Type | 8-K |
| Filed Date | Jun 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Oric Pharma held a shareholder vote on June 12th, details to follow.
AI Summary
Oric Pharmaceuticals, Inc. filed an 8-K on June 14, 2024, to report on matters submitted to a vote of its security holders on June 12, 2024. The filing does not detail the specific proposals voted upon or the outcomes.
Why It Matters
This filing indicates that Oric Pharmaceuticals held a shareholder vote, which could have implications for corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any new financial or operational risks.
Key Players & Entities
- Oric Pharmaceuticals, Inc. (company) — Registrant
- June 12, 2024 (date) — Date of earliest event reported
- June 14, 2024 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Oric Pharmaceuticals' security holders on June 12, 2024?
The filing does not specify the exact proposals voted on during the June 12, 2024 meeting.
What was the outcome of the shareholder vote on June 12, 2024?
The filing does not disclose the results or outcomes of the shareholder vote.
Is this filing related to a specific corporate action or event?
This filing is specifically to report on 'Submission of Matters to a Vote of Security Holders'.
When was the report filed with the SEC?
The Form 8-K was filed on June 14, 2024.
What is Oric Pharmaceuticals' principal executive office address?
The address is 240 E. Grand Ave, 2nd Floor, South San Francisco, CA 94080.
Filing Stats: 580 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-06-14 16:05:55
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share ORIC The Nasdaq Global Se
Filing Documents
- d765804d8k.htm (8-K) — 28KB
- 0001193125-24-161593.txt ( ) — 151KB
- oric-20240612.xsd (EX-101.SCH) — 3KB
- oric-20240612_lab.xml (EX-101.LAB) — 18KB
- oric-20240612_pre.xml (EX-101.PRE) — 11KB
- d765804d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORIC PHARMACEUTICALS, INC. Date: June 14, 2024 By: /s/ Christian V. Kuhlen, M.D. Christian V. Kuhlen, M.D. General Counsel